Patrick Malone Newsletter - January 2011

In this issue: Rating Health Care Stories for Accuracy; Overrated Medications: A Top 5 List; "Miranda warnings" On Health Products; Check Out Our Previous Tips; and more.

Every day, a deluge of "facts" about health and medicine washes over each of us. How can you tell what is real, what is marketing hype, and what is sheer nonsense?

In this month's newsletter, I've gathered some resources to help readers sort through the news and make informed judgments.

You should know my tilt before reading further. I am a skeptic of the new. The odds are very high with most medical news that someone somewhere stands to make a gazillion bucks by pushing their new product onto gullible consumers. Or if not a gazillion, at least fame is in the offing.

Please see full publication below for more information.

LOADING PDF: If there are any problems, click here to download the file.

Written by:

Published In:

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Patrick Malone & Associates P.C. | DC Injury Lawyers | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »

All the intelligence you need, in one easy email:

Great! Your first step to building an email digest of JD Supra authors and topics. Log in with LinkedIn so we can start sending your digest...

Sign up for your custom alerts now, using LinkedIn ›

* With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name.